{"id":"https://openalex.org/W4394599487","doi":"https://doi.org/10.1212/wnl.0000000000205163","title":"SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany (P9-9.010)","display_name":"SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany (P9-9.010)","publication_year":2024,"publication_date":"2024-04-09","ids":{"openalex":"https://openalex.org/W4394599487","doi":"https://doi.org/10.1212/wnl.0000000000205163"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000205163","doi":"https://doi.org/10.1212/wnl.0000000000205163","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000205163","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020519718","display_name":"Yaroslav Winter","orcid":"https://orcid.org/0000-0001-9854-4038","observed_orcids":["https://orcid.org/0000-0001-9854-4038"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Yaroslav Winter","raw_affiliation_strings":["1. Johannes Gutenberg-University, Mainz Comprehensive Epilepsy and Sleep Medicine Center, Department of Neurology, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1. Johannes Gutenberg-University, Mainz Comprehensive Epilepsy and Sleep Medicine Center, Department of Neurology, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000989945","display_name":"Geert Mayer","orcid":"https://orcid.org/0000-0002-5147-4383","observed_orcids":["https://orcid.org/0000-0002-5147-4383"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Geert Mayer","raw_affiliation_strings":["Philipps-Universit\u00e4t Marburg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philipps-Universit\u00e4t Marburg","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088552578","display_name":"Heike Bene\u0161","orcid":"https://orcid.org/0000-0002-4236-6508","observed_orcids":["https://orcid.org/0000-0002-4236-6508"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heike Benes","raw_affiliation_strings":["5. Somni bene GmbH Institut f\u00fcr Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Germany, Heilig Geist-Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5. Somni bene GmbH Institut f\u00fcr Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Germany, Heilig Geist-Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073592911","display_name":"Lothar Burghaus","orcid":"https://orcid.org/0000-0002-7883-190X","observed_orcids":["https://orcid.org/0000-0002-7883-190X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lothar Burghaus","raw_affiliation_strings":["Department of Neurology, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Cologne, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113172693","display_name":"Irnesha Abeynayake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irnesha Abeynayake","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090316209","display_name":"Samantha Floam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Floam","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103222359","display_name":"Hannah Kwak","orcid":"https://orcid.org/0009-0004-8509-046X","observed_orcids":["https://orcid.org/0009-0004-8509-046X"]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Kwak","raw_affiliation_strings":["Axsome Therapeutics (Former)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics (Former)","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gregory Parks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119587","display_name":"Axsome Therapeutics (United States)","ror":"https://ror.org/02cvw8c86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Parks","raw_affiliation_strings":["Axsome Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Axsome Therapeutics","institution_ids":["https://openalex.org/I4210119587"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018576617","display_name":"Ulf Kallweit","orcid":"https://orcid.org/0000-0003-1975-6919","observed_orcids":["https://orcid.org/0000-0003-1975-6919"]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulf Kallweit","raw_affiliation_strings":["University Witten/Herdecke, Center for Biomedical Education and Researchand Professorship for Narcolepsy and Hypersomnolence Research, Witten, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Witten/Herdecke, Center for Biomedical Education and Researchand Professorship for Narcolepsy and Hypersomnolence Research, Witten, Germany","institution_ids":["https://openalex.org/I155976169"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"102","issue":"7_supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10234","display_name":"Obstructive Sleep Apnea Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10234","display_name":"Obstructive Sleep Apnea Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11373","display_name":"Sleep and Work-Related Fatigue","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solriamfetol","display_name":"solriamfetol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obstructive-sleep-apnea","display_name":"obstructive sleep apnea","score":0.9950000047683716},{"id":"https://openalex.org/keywords/excessive-daytime-sleepiness","display_name":"excessive daytime sleepiness","score":0.9959999918937683},{"id":"https://openalex.org/keywords/wakefulness-promoting-agents","display_name":"wakefulness-promoting agents","score":0.9779999852180481},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.7129999995231628},{"id":"https://openalex.org/keywords/epworth-sleepiness-scale","display_name":"Epworth Sleepiness Scale","score":0.8790000081062317},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6520000100135803},{"id":"https://openalex.org/keywords/german-patients","display_name":"German patients","score":0.6650000214576721},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6470000147819519},{"id":"https://openalex.org/keywords/follow-up-outcomes","display_name":"follow-up outcomes","score":0.6549999713897705},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.3100000023841858},{"id":"https://openalex.org/keywords/physician-satisfaction","display_name":"physician satisfaction","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C154775046","wikidata":"https://www.wikidata.org/wiki/Q188","display_name":"German","level":2,"score":0.7859621047973633},{"id":"https://openalex.org/C184866935","wikidata":"https://www.wikidata.org/wiki/Q191010","display_name":"Titration","level":2,"score":0.7231726050376892},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6720196008682251},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4986076354980469},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32045215368270874},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26768290996551514},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13973075151443481},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.10888016223907471},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.043764740228652954},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000205163","doi":"https://doi.org/10.1212/wnl.0000000000205163","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000205163","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408026400","https://openalex.org/W4378611502","https://openalex.org/W4394978797","https://openalex.org/W4289793448","https://openalex.org/W4318384130","https://openalex.org/W4367296879","https://openalex.org/W3205493815","https://openalex.org/W3201972166","https://openalex.org/W3158027945","https://openalex.org/W3202603063"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"characterize":[2],"real-world":[3,261],"dosing/titration":[4],"strategies":[5],"among":[6],"German":[7,68,70,267],"physicians":[8,291],"initiating":[9],"solriamfetol":[10,83,99,169,228,238,271],"and":[11,42,85,131,133,160,173,196,214,256,278,287,290],"patient":[12],"outcomes":[13],"following":[14],"initiation.":[15],"Background:":[16],"Excessive":[17],"daytime":[18],"sleepiness":[19],"(EDS)":[20],"is":[21],"a":[22,62,81,264,317,337,356,375,394,414,434,453,474,499,605,625,644,663,682,701,727,752,777,801,826],"symptom":[23],"of":[24,35,90,136,168,266,312,332,351,370,389,409,429,448,469,494,527,546,560,574,600,620,639,658,677,696,722,747,772,796,821],"obstructive":[25],"sleep":[26,247],"apnea":[27,36],"(OSA)":[28],"that":[29],"can":[30,43],"persist":[31],"despite":[32],"efficacious":[33],"suppression":[34],"via":[37],"primary":[38],"airway":[39],"therapy":[40],"(PAT)":[41],"be":[44],"managed":[45],"with":[46,57,74,217,269],"wake-promoting":[47],"agents,":[48],"including":[49],"solriamfetol,":[50],"an":[51,525,544,558,572],"approved":[52],"treatment":[53,91],"for":[54,314,320,334,340,353,359,372,378,391,397,411,417,431,437,450,455,471,482,496,502,522,541,555,569,602,607,622,627,641,646,660,665,679,684,698,709,724,735,749,760,774,785,798,809,823,834],"EDS":[55,75,107,114,121,226],"associated":[56],"OSA.":[58],"Design/Methods:":[59],"SURWEY":[60],"was":[61,153,178,191,272,280],"retrospective":[63],"chart":[64],"review":[65],"conducted":[66],"by":[67,157],"physicians.":[69],"patients":[71,140,182,236,268,289],"(n=83)":[72,193],"diagnosed":[73],"due":[76],"to":[77,112,508,514],"OSA,":[78,270],"had":[79,86],"reached":[80],"stable":[82],"dose,":[84],"completed":[87],"\u22656":[88,241],"weeks":[89],"were":[92,95,170,230,253,284,300],"included.":[93],"Patients":[94],"classified":[96],"based":[97],"on":[98,316,336,355,374,393,413,433,473,498,700,726,751,776,800,825],"initiation":[100,151,195,229],"strategy:":[101],"1)":[102],"changeover":[103,161],"(switched":[104],"from":[105,211,220,263],"existing":[106],"medication[s]),":[108,115],"2)":[109],"add-on":[110,158],"(added":[111],"current":[113,120],"or":[116,477,704,730,755,780,804,829],"3)":[117],"new-to-therapy":[118,154],"(no":[119],"medication).":[122],"Efficacy":[123],"measures":[124],"included":[125],"the":[126,310,330,349,368,387,407,427,446,467,492,598,618,637,656,675,694,720,745,770,794,819],"Epworth":[127],"Sleepiness":[128],"Scale":[129],"(ESS)":[130],"patient-":[132],"physician-reported":[134],"perceptions":[135],"improvement.":[137],"Results:":[138],"All":[139],"(mean":[141],"age=49":[142],"years;":[143],"65%":[144],"male)":[145],"used":[146],"PAT.":[147],"The":[148,163],"most":[149,164,288],"common":[150,165],"type":[152],"(n=62),":[155],"followed":[156],"(n=12),":[159],"(n=9).":[162],"starting":[166],"doses":[167],"37.5":[171,276],"(n=57;69%)":[172],"75":[174],"(n=23;28%)":[175],"mg/day.":[176],"Solriamfetol":[177],"titrated":[179],"in":[180,225,294,309,329,348,367,386,406,426,445,466,491,533,581,588,597,617,636,655,674,693,719,744,769,793,818],"53":[181],"(64%);":[183],"often":[184],"within":[185],"7":[186],"days.":[187],"Mean\u00b1SD":[188],"ESS":[189,202,208,282],"score":[190],"16.0\u00b13.2":[192],"at":[194,198,275],"10.7\u00b13.9":[197],"follow-up":[199],"(n=83;":[200],"mean":[201,207,218],"decrease=":[203],"5.4\u00b13.6).":[204],"Across":[205],"subgroups,":[206],"scores":[209],"ranged":[210],"15.9\u201316.6":[212],"(initiation)":[213],"10.4\u201312.2":[215],"(follow-up),":[216],"decreases":[219],"5.3\u20135.7":[221],"points.":[222],"Improvement":[223],"rates":[224],"after":[227],"patient-reported,":[231],"90%;":[232],"physician-reported,":[233],"89%.":[234],"Most":[235],"reported":[237],"effects":[239,252],"lasted":[240],"hours":[242],"(74%)":[243],"without":[244],"altering":[245],"night-time":[246],"quality":[248],"(91%).":[249],"Common":[250],"adverse":[251],"headache,":[254],"insomnia,":[255],"irritability.":[257],"Conclusions:":[258],"In":[259],"this":[260],"data":[262],"cohort":[265],"typically":[273],"initiated":[274],"mg/day":[277],"titration":[279],"common.":[281],"improvements":[283],"clinically":[285],"meaningful,":[286],"perceived":[292],"improvement":[293],"EDS.":[295],"No":[296],"new":[297],"safety":[298],"signals":[299],"reported.":[301],"Disclosure:":[302],"Dr.":[303,323,342,361,380,400,420,439,460,485,535,549,563,577,584],"Winter":[304,324,343,362,381,401,421],"has":[305,325,344,363,382,402,422,441,462,487,506,512,518,531,537,551,565,579,586,593,613,632,651,670,689,715,740,765,789,814],"received":[306,326,345,364,383,403,423,442,463,488,519,538,552,566,594,614,633,652,671,690,716,741,766,790,815],"personal":[307,327,346,365,384,404,424,443,464,489,520,539,553,567,595,615,634,653,672,691,717,742,767,791,816],"compensation":[308,328,347,366,385,405,425,444,465,490,521,540,554,568,596,616,635,654,673,692,718,743,768,792,817],"range":[311,331,350,369,388,408,428,447,468,493,599,619,638,657,676,695,721,746,771,795,820],"$0-$499":[313],"serving":[315,335,354,373,392,412,432,451,472,497,523,542,556,570,603,623,642,661,680,699,725,750,775,799,824],"Speakers":[318,338,357,376,395,415,435,500],"Bureau":[319,339,358,377,396,416,436,501],"Bayer":[321],"AG.":[322],"$500-$4,999":[333,352,371,390,410,430,470,495,748,773,822],"BIAL.":[341],"Eisai.":[360],"LivaNova.":[379],"UCB":[398,835],"Pharma.":[399,459],"Jazz":[418,575,589,647,761],"pharmaceuticals.":[419],"Bioprojet.":[438],"Mayer":[440,461,486],"$5,000-$9,999":[449,601,621,640,659,678,697,723,797],"as":[452,524,543,557,571,604,624,643,662,681],"Consultant":[454,606,626,645,664,683],"Janssen,":[456],"Idorsia,":[457,483],"NLS":[458],"Scientific":[475,702,728,753,778,802,827],"Advisory":[476,703,729,754,779,803,828],"Data":[478,705,731,756,781,805,830],"Safety":[479,706,732,757,782,806,831],"Monitoring":[480,707,733,758,783,807,832],"board":[481,708,734,759,784,808,833],"Takeda.":[484],"Idorsia.":[503],"Heike":[504],"Benes":[505],"nothing":[507,513],"disclose.":[509,515],"Lothar":[510],"Burghaus":[511],"Iresha":[516,529],"Abeynayake":[517,530],"employee":[526,545,559,573],"Axsome.":[528,534],"stock":[532,580,587],"Floam":[536],"Axsome":[547,561,582],"Therapeutics.":[548,562,583],"Parks":[550,564,578,585],"Pharmaceuticals.":[576,590],"Prof.":[591,611,630,649,668,687,713,738,763,787,812],"Kallweit":[592,612,631,650,669,688,714,739,764,788,813],"AOP":[608,710],"Orphan":[609,711],".":[610,629,648,667,686,712,737,762,811,836],"Bioprojet":[628,736],"Harmony":[666],"Takeda":[685,810],"Harmony.":[786]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2024-04-10T00:00:00"}